Part of: S&P 100 · Healthcare & Devices · Income & Dividends

Abbott Laboratories (ABT)

AI-powered earnings call analysis for Abbott Laboratories. Get insights from quarterly earnings reports with our AI-generated podcast. Educational content only - not investment advice.

15 episodes 5 languages

Next Episode

Abbott Laboratories earnings call scheduled for Oct 14, 2026 (before market open)

New episode expected Oct 15, 2026

Latest Episode

Q2 2026 Earnings

6:36 • 7/16/2026

Abbott Laboratories (ABT) - Q2 2026

0:00

6:36

Speed:

Q2 2026 Earnings

8:39 • 2026/7/16

Abbott Laboratories (ABT) - Q2 2026

0:00

8:39

Speed:

Q2 2026 Earnings

10:30 • 16/07/2026

Abbott Laboratories (ABT) - Q2 2026

0:00

10:30

Speed:

Q2 2026 Earnings

8:54 • 16/7/2026

Abbott Laboratories (ABT) - Q2 2026

0:00

8:54

Speed:

Q2 2026 Earnings

6:55 • 16.7.2026

Abbott Laboratories (ABT) - Q2 2026

0:00

6:55

Speed:

All Episodes

EN - English (3) CN - 中文 (3) FR - Français (3) ES - Español (3) DE - Deutsch (3)

Q2 2026 Earnings

6:36

Abbott raised FY EPS guidance to $5.45-$5.60 on Q2 beat of $1.31 EPS and 4.8% sales growth, reaffirming 6.5%-7.5% sales guidance with momentum from nutrition, EP, diagnostics, and Libre.

Q1 2026 Earnings

8:14

Abbott delivered Q1 adjusted EPS of $1.15 (+6% YoY) with 3.7% comparable sales growth, completed Exact Sciences acquisition on 03/23/2026, and raised FY2026 comparable sales guidance to 6.5%-7.5% with EPS midpoint of $5.48.